Literature DB >> 1958084

Treatment of osteoporosis: current and future.

M D Stone1, D J Hosking.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1958084      PMCID： PMC1004523          DOI： 10.1136/ard.50.10.663

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  37 in total

Review 1.  Estrogens, bone loss and preservation.

Authors:  C Christiansen; R Lindsay
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

2.  Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.

Authors:  R Lindsay; D M Hart; D Purdie; M M Ferguson; A S Clark; A Kraszewski
Journal:  Clin Sci Mol Med       Date:  1978-02

3.  Prevention of spinal osteoporosis in oophorectomised women.

Authors:  R Lindsay; D M Hart; C Forrest; C Baird
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

4.  Fluoroscopically guided skinny-needle aspirative biopsy in normal and suspected lymph nodes in urologic cancer.

Authors:  V F Nadalini; C Giglio; G P Bruttini; M Medica; M Piccardo; C Ruggeri
Journal:  Urol Int       Date:  1983       Impact factor: 2.089

5.  Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.

Authors:  M S Christensen; C Hagen; C Christiansen; I Transbøl
Journal:  Am J Obstet Gynecol       Date:  1982-12-15       Impact factor: 8.661

6.  Menopausal estrogen therapy and hip fractures.

Authors:  A Paganini-Hill; R K Ross; V R Gerkins; B E Henderson; M Arthur; T M Mack
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

7.  Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors:  C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

8.  Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.

Authors:  B F Boyce; L Smith; I Fogelman; E Johnston; S Ralston; I T Boyle
Journal:  Lancet       Date:  1984-04-14       Impact factor: 79.321

9.  Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

Authors:  N S Weiss; C L Ure; J H Ballard; A R Williams; J R Daling
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

10.  Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis.

Authors:  J C Gerster; S A Charhon; P Jaeger; G Boivin; D Briancon; A Rostan; C A Baud; P J Meunier
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10
View more
  2 in total

Review 1.  Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  C J Dunn; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

2.  Diagnosis of osteoporosis in statin-treated patients is dose-dependent.

Authors:  Michael Leutner; Caspar Matzhold; Luise Bellach; Carola Deischinger; Jürgen Harreiter; Stefan Thurner; Peter Klimek; Alexandra Kautzky-Willer
Journal:  Ann Rheum Dis       Date:  2019-09-26       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.